FTC Moves To Crack Down On Transgender Procedures For Minors

The Federal Trade Commission is requesting public comment on so-called “gender-affirming care” for minors.

The inquiry seeks “to better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care’, especially as it relates to minors.” The FTC will accept “comment on any issues or concerns,” including “written data, advertisements, social media posts, disclosures, or empirical research,” a press release said.

The FTC is investigating whether minors and consumers have been harmed by transgender medical procedures and if medical professionals “have violated Sections 5 and 12 of the FTC Act by failing to disclose material risks associated with ‘gender-affirming care’ or making false or unsubstantiated claims about the benefits or effectiveness of ‘gender-affirming care.’”

The request for public comment is the latest in the FTC’s campaign against the transgender medical industry.

In May, The Daily Wire first reported on an FTC memo about a workshop on “gender-affirming care.” The FTC, an agency tasked with protecting American consumers, often holds workshops before initiating legal action against an industry.

“Under the Federal Trade Commission Act, the FTC is provided broad authority to protect consumers from unfair and deceptive trade acts and practices,” the memo said. “There is now considerable reason to believe that the doctors and medical providers pushing [gender-affirming care] on minors are knowingly deceiving parents by exaggerating [gender-affirming care’s] ‘benefits’ and downplaying its harmful side effects.”